Načítá se...
Soluble Endoglin (sCD105) as a Novel Biomarker for Detecting Aggressive Prostate Cancer
BACKGROUND/AIM: We have previously found elevated levels of endoglin (CD105) in the prostate cancer (PC) tissue of men with poor prognosis, compared to men with indolent disease. Herein, we examined whether plasma levels of the soluble form of CD105 (sCD105) differ according to the PC grade at diagn...
Uloženo v:
| Vydáno v: | Anticancer Res |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7768804/ https://ncbi.nlm.nih.gov/pubmed/32132043 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/anticanres.14088 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|